12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movements in Wednesday's intraday session, with notable gainers including Cogent Biosciences, Larimar Therapeutics, BioXcel Therapeutics, Greenwich LifeSciences, Electromed, and Puma Biotechnology. On the losing end, Anitra, QuidelOrtho, NeuroOne Medical Tech, Renalytix, Sientra, and Sunshine Biopharma saw declines. Earnings reports influenced some of these movements.
February 14, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
QuidelOrtho's stock fell 29.1% to $47.34 after its Q4 earnings report.
The decline in QuidelOrtho's stock price post-Q4 earnings suggests the market reacted negatively to its financial results or future outlook.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 85
POSITIVE IMPACT
Cogent Biosciences stock surged 64% to $8.96, with a market cap of $771.2 million.
The significant increase in Cogent Biosciences' stock price suggests positive investor sentiment, potentially due to company-specific news or broader market trends affecting the health care sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Electromed's stock rose 22.61% to $12.43 following its Q2 earnings report.
Electromed's stock price increase is directly linked to its Q2 earnings report, indicating a positive market reaction to the company's financial performance.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 85